GRAIL (GRAL) Competitors $34.24 +1.09 (+3.29%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$34.20 -0.04 (-0.11%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. OPCH, RDNT, SHC, BTSG, SGRY, WGS, CON, PRVA, VCYT, and ADUSShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Veracyte (VCYT), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Option Care Health RadNet Sotera Health BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Privia Health Group Veracyte Addus HomeCare Option Care Health (NASDAQ:OPCH) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Is OPCH or GRAL more profitable? Option Care Health has a net margin of 3.93% compared to GRAIL's net margin of -329.86%. Option Care Health's return on equity of 17.53% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health3.93% 17.53% 7.17% GRAIL -329.86%-16.64%-14.02% Which has stronger valuation and earnings, OPCH or GRAL? Option Care Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.37B0.87$211.82M$1.2522.99GRAIL$134.29M9.19-$2.03B-$13.11-2.61 Does the media prefer OPCH or GRAL? In the previous week, Option Care Health had 16 more articles in the media than GRAIL. MarketBeat recorded 21 mentions for Option Care Health and 5 mentions for GRAIL. Option Care Health's average media sentiment score of 1.70 beat GRAIL's score of 0.46 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 15 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive GRAIL 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, OPCH or GRAL? Option Care Health has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, GRAIL has a beta of 3.26, indicating that its share price is 226% more volatile than the S&P 500. Do analysts prefer OPCH or GRAL? Option Care Health presently has a consensus price target of $35.75, indicating a potential upside of 24.39%. GRAIL has a consensus price target of $31.50, indicating a potential downside of 8.00%. Given Option Care Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Option Care Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Do insiders and institutionals have more ownership in OPCH or GRAL? 98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by insiders. Comparatively, 1.9% of GRAIL shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryOption Care Health beats GRAIL on 13 of the 16 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19B$3.11B$5.75B$9.62BDividend YieldN/A2.23%4.40%4.10%P/E Ratio-2.6121.2831.2826.05Price / Sales9.19346.33433.91193.87Price / Cash1.1543.1937.7358.48Price / Book0.538.129.536.61Net Income-$2.03B-$54.72M$3.26B$265.65M7 Day Performance5.58%2.62%2.13%2.03%1 Month Performance-16.24%2.68%2.81%-0.31%1 Year Performance122.19%10.93%30.68%19.06% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL0.999 of 5 stars$34.24+3.3%$31.50-8.0%+107.0%$1.19B$134.29M-2.611,360Insider TradeOPCHOption Care Health4.5515 of 5 stars$27.85-1.2%$35.75+28.4%-7.5%$4.58B$5.00B22.288,088News CoveragePositive NewsInsider TradeGap UpRDNTRadNet3.281 of 5 stars$62.00+16.2%$69.60+12.3%+9.4%$4.00B$1.83B-144.1811,021News CoverageInsider TradeHigh Trading VolumeSHCSotera Health1.3778 of 5 stars$14.06+0.6%$16.00+13.8%+8.2%$3.97B$1.10B175.773,000News CoverageHigh Trading VolumeBTSGBrightSpring Health Services1.6765 of 5 stars$20.66-0.6%$25.67+24.2%+107.8%$3.68B$11.27B66.6535,000Positive NewsSGRYSurgery Partners2.9888 of 5 stars$22.74-3.8%$33.00+45.1%-17.5%$3.03B$3.11B-15.9015,000News CoverageWGSGeneDx2.176 of 5 stars$110.54+5.1%$101.63-8.1%+278.2%$3.02B$305.45M2,210.801,200Positive NewsInsider TradeCONConcentra Group Holdings Parent2.3276 of 5 stars$21.47-0.7%$28.50+32.7%+2.2%$2.77B$1.90B18.0411,250News CoveragePositive NewsPRVAPrivia Health Group4.2736 of 5 stars$20.31-1.3%$28.00+37.9%+9.9%$2.53B$1.74B184.651,140News CoveragePositive NewsAnalyst UpgradeVCYTVeracyte2.8242 of 5 stars$27.99+2.3%$40.90+46.1%-0.2%$2.15B$445.76M84.82790News CoveragePositive NewsADUSAddus HomeCare4.9216 of 5 stars$111.95+1.6%$142.86+27.6%-10.6%$2.03B$1.15B24.7149,703News CoverageAnalyst ForecastInsider Trade Related Companies and Tools Related Companies Option Care Health Alternatives RadNet Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives Surgery Partners Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Veracyte Alternatives Addus HomeCare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access